As of 9:59am ET
| -0.025 / -2.04%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +66.67% increase from the last price of 1.20.
The current consensus among 1 polled investment analysts is to Hold stock in Titan Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.